Test Price
2,800 AED✅ Home Collection Available
HSPD1 Gene SPG13 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل HSPD1 Gene SPG13 الجيني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing.
- Premium Logistics: Complimentary Hospital-Grade Home Collection via ISO Certified Cold-Chain Transport & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-Licensed Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview
The HSPD1 Gene SPG13 Genetic Test utilizes Genetic Test is essential for definitive molecular diagnosis of Hereditary Spastic Paraplegia type 13 (SPG13) and guides family risk assessment and genetic counseling.
| Feature | Our Test (ISO Certified) | Closest Alternative |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity (full gene coverage) | Sanger sequencing (single‑variant analysis, may miss novel mutations) |
| Methodology | NGS (Illumina NovaSeq X Plus) with bioinformatic validation | Capillary electrophoresis (lower throughput) |
| Turnaround Time | 3 to 4 Weeks (including clinical report interpretation) | 4–6 Weeks (often without integrated counseling) |
Physician Insight & Safety Protocol
“As a consultant neurologist, I emphasize that genetic test results must be correlated with clinical phenotype, family history, and expert neurological evaluation. A positive HSPD1 mutation confirms a diagnosis but requires comprehensive genetic counseling to understand inheritance implications. I advise all patients to discuss results with their neurologist and genetic counselor before making any health decisions.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test is for diagnostic clarification and does not replace ongoing neurological management.
Exclusion Criteria & ER Red Flags
- Exclusion: Blood transfusion within the last 3 months, lack of informed consent, minors without legal guardian consent (UAE CDS Law 2026).
- ER Red Flags: Sudden-onset paraplegia, acute bilateral lower limb weakness, loss of bladder/bowel control, or severe psychiatric symptoms — these may indicate non‑genetic emergencies requiring immediate hospital evaluation. Do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the purpose of the HSPD1 Gene SPG13 NGS Test?
This NGS test detects HSPD1 gene mutations causing SPG13 to confirm diagnosis and inform family risk. The test is indicated for individuals with progressive lower limb spasticity, gait disturbance, and a family history of hereditary spastic paraplegia. A positive result enables accurate genetic counseling, reproductive planning, and personalised surveillance.
يكشف هذا الاختبار عن طفرات جين HSPD1 المسببة للشلل النصفي التشنجي الوراثي SPG13 لتأكيد التشخيص وتحديد المخاطر العائلية. يُوصى به للأشخاص الذين يعانون من تشنجات في الأطراف السفلية واضطراب في المشي، مع تاريخ عائلي للحالة.
2. How is the test performed?
We collect blood or DNA FTA card at home using ISO‑certified process for precise testing. A certified phlebotomist arrives within your preferred 2‑hour window (8 AM – 11 PM), maintains cold‑chain integrity, and ensures minimal discomfort. No fasting is required unless otherwise advised.
نقوم بجمع عينة دم أو بطاقة الحمض النووي FTA في المنزل باستخدام عملية معتمدة من الآيزو. يصل الفني المعتمد خلال فترة زمنية مدتها ساعتان مع الحفاظ على سلسلة التبريد، ولا يتطلب الصيام إلا إذا أشار الطبيب بخلاف ذلك.
3. What do the results mean?
Positive result means HSPD1 mutation causing SPG13; negative excludes only this gene, not all causes. A positive report identifies the exact variant and confirms the diagnosis. A negative report does not rule out other genetic or non‑genetic causes of spastic paraplegia, so further neurologic workup may be needed.
النتيجة الإيجابية تعني وجود طفرة HSPD1 المسببة للمرض، والنتيجة السلبية تستبعد هذا الجين فقط وليس كل الأسباب. التقرير الإيجابي يحدد الطفرة ويؤكد التشخيص. أما السلبي فلا ينفي الأسباب الأخرى للشلل التشنجي، وقد يحتاج المريض لمزيد من التقييم العصبي.
UAE Regulatory Compliance & Certifications
This genetic is conducted in accordance with Federal Decree‑Law No. 41 of 2024 (Article 87), CDS Law 2026 (minors), and the UAE Personal Data Protection Law (PDPL). All genetic data is handled with strict confidentiality and anonymisation.
Laboratory Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453.
ICD‑10‑CM Codes: G11.4 (Hereditary spastic paraplegia), Z14.8 (Genetic susceptibility to other disease), Z82.79 (Family history of other diseases of the nervous system). LOINC: 86254‑4 (NGS panel for hereditary neurological disorders).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians